Daniel Paul Teufel

This inventor holds 31 USPTO granted patents and 20 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in Bicyclic Peptide Ligands. Top assignees: Bicyclerd Limited, Bicycletx Limited, Bicycle Therapeutics Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Paul Teufel. Retrieved from https://idiyas.com/inventor/daniel-paul-teufel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 31 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 32)

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 328(Granted Patents)

Location History:

Hergatz, DE (2018)
Cambridge, GB (2014 - 2024)

Company Filing History:

Bicycle Therapeutics Limited

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Bicyclic Peptide Ligands

CD38

MT1-MMP

EphA2

Cancer Treatment

Polypeptide Specificity

Peptide Derivatives

Peptide Libraries

Multispecific Peptides

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552837 - BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF (2026-02-17),

2. 12516084 - BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CD38 (2026-01-06),

3. 12491253 - BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP (2025-12-09),

4. 12377155 - Bicyclic peptide ligands specific for PSMA (2025-08-05),

5. 12350343 - Bicyclic peptide ligands specific for MT1-MMP (2025-07-08),

6. 12318454 - Bicyclic peptide ligands specific for MT1-MMP (2025-06-03),

7. 11912794 - Modulation of structured polypeptide specificity (2024-02-27),

8. 11814447 - Peptide ligands for binding to EphA2 (2023-11-14),

9. 11753444 - Modulation of structured polypeptide specificity (2023-09-12),

10. 11746126 - Bicyclic peptide ligands with detectable moieties and uses thereof (2023-09-05),

11. 11730819 - Peptide derivatives having novel linkage structures (2023-08-22),

12. 11672868 - Bicyclic peptide ligands specific for MT1-MMP (2023-06-13),

13. 11623012 - Bicyclic peptide ligands specific for EphA2 (2023-04-11),

14. 11433137 - Compounds for treating cancer (2022-09-06),

15. 11241473 - Bicyclic peptide ligands and uses thereof (2022-02-08),

Title: Daniel Paul Teufel - Innovative Inventor from Cambridge, GB

Introduction: Daniel Paul Teufel is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Daniel Paul Teufel holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Daniel Paul Teufel has established himself as a leading figure in the world of inventions, with numerous successful projects that have had a significant impact on society.

Collaborations: Throughout his career, Daniel Paul Teufel has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Daniel Paul Teufel's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.